Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Prostatic Vapor Ablation - Multicenter, Controlled Study for the Treatment of BPH (Rezūm II)

NCT01912339 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01912339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01912339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Prostatic Vapor Ablation - Multicenter, Controlled Study for the Treatment of BPH (Rezūm II)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2013
Completion date
October 17, 2016
Enrollment
197 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, lower urinary tract symptom